what is the icd 10 code for bacterial vaginosis

by Dr. Gregg Kutch I 9 min read

ICD-10 Code for Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere- N77. 1- Codify by AAPC.

What is the ICD 10 code for BV?

Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere

  • N77.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • Short description: Vaginitis, vulvitis and vulvovaginitis in dis classd elswhr
  • The 2021 edition of ICD-10-CM N77.1 became effective on October 1, 2020.

More items...

What is the diagnosis code for vaginal discharge?

The use of ICD-10 code N89.8 can also apply to:

  • Fluor (vaginalis)
  • Hydrocolpos (congenital)
  • Hydrometrocolpos
  • Leukorrhea

What is the diagnosis code for urinary tract infection?

Urinary tract infection, site not specified N39. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. How do you code a urinary tract infection? Code 599.0 is reported to identify UTI as the localized infection. Code E879.

What is the diagnosis for bacterial vaginosis?

Bacterial vaginosis is not a sexually transmitted infection, but rather an overgrowth of bacteria naturally found in the vagina, which upsets the balance of the natural vaginal microbiome and leads to not only distressing symptoms of odor and discharge ...

image

What is the ICD-10 code for vaginal infection?

2022 ICD-10-CM Diagnosis Code N76. 0: Acute vaginitis.

What is the ICD-10 code for bacterial infections?

ICD-10 code: A49. 9 Bacterial infection, unspecified.

What is the ICD-10 code for yeast infection?

ICD-10 code B37. 3 for Candidiasis of vulva and vagina is a medical classification as listed by WHO under the range - Certain infectious and parasitic diseases .

What is the ICD-10 code for discharge?

ICD-10 code R36. 9 for Urethral discharge, unspecified is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .

What is the ICD-10 code for unspecified infection?

ICD-10 code B99. 9 for Unspecified infectious disease is a medical classification as listed by WHO under the range - Certain infectious and parasitic diseases .

Can F07 81 be used as a primary diagnosis?

Our physicians have used IDC-10 code F07. 81 as the primary diagnosis for patients presenting with post concussion syndrome.

What is the medical term for yeast infection?

Candidiasis in the vagina is commonly called a “vaginal yeast infection.” Other names for this infection are “vaginal candidiasis,” “vulvovaginal candidiasis,” or “candidal vaginitis.”

What is Funguria?

funguria refers to the presence of fungi in the urine 1,2,3,4. most commonly arises in catheterized, instrumented, or obstructed patients 1,2,3,4. Candida species are the most common fungal organisms isolated from urine 1,2,3,4.

What B37 9?

9: Candidiasis, unspecified.

What is the ICD-10 code for vaginal odor?

Other specified noninflammatory disorders of vagina. N89. 8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM N89.

What is the ICD-10 code for vaginal irritation?

Other inflammation of vagina and vulva ICD-10-CM N76. 89 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):

What is the ICD-10 code for atrophic vaginitis?

ICD-10 code: N95. 2 Postmenopausal atrophic vaginitis.

What is the ICd 10 code for bacterial vaginosis?

Based on the ICD-10 code of classification, bacterial vaginosis is allocated the code N76.0, which represents a billable code that may be applied in indicating a diagnosis of reimbursement. The coding rules of ICD-10-CM dictate that the code N76.0 should be applied on female patients. In addition, the code N76.0 is also grouped in groups related to diagnosis.

What is the ICd 10 code for a vaginal discharge?

First, according to ICD-10, N76.0 is any disorder that is characteristic of a process of infection that involves the vagina. Secondly, N76.0 is a process of infection that affects the vagina with symptoms of purulent discharge along with pain.

When was the ICD-9 code used?

Generally, diseases are classified internationally using codes. Initially, before the 30th of September 2015, the ICD-9 codes were used for classification. However, after the 1st of October 2015 ICD-10 codes of classification were adopted.

What is the name of the infection that complicates pregnancy, childbirth and the puerperium?

gonococcal infections complicating pregnancy, childbirth and the puerperium ( O98.2) infections with a predominantly sexual mode of transmission NOS complicating pregnancy, childbirth and the puerperium ( O98.3) syphilis complicating pregnancy, childbirth and the puerperium ( O98.1)

When will the ICD-10-CM O23.599 be released?

The 2022 edition of ICD-10-CM O23.599 became effective on October 1, 2021.

What is a vaginosis diagnosis?

Diagnosis of vaginitis is based on clinical symptoms, pH of the vaginal fluid and microscopic examination of the discharge. Symptoms are not present in approximately 50 % of women with bacterial vaginosis infection.

What is the best test for bacterial vaginosis?

The Centers for Disease Control and Prevention (2010) also recommended the gram stain as the gold standard for diagnosis of bacterial vaginosis, and recommend use of Amsel's criteria if a gram stain is not available. Similar to the BASHH guidelines, the CDC states that the BVBlue, the Affirm VIP, and the Pip Activity TestCard "have acceptable performance characteristics" compared to the gram stain , but make no recommendation for their use. The CDC stated that a card test is available for the detection of elevated pH and trimethylamine, but it has low sensitivity and specificity and therefore is not recommended. The CDC also stated that PCR also has been used in research settings for the detection of a variety of organisms associated with bacterial vaginosis, but evaluation of its clinical utility is uncertain. The CDC stated that culture of G. vaginalis is not recommended as a diagnostic tool because it is not specific, and that cervical Pap tests have no clinical utility for the diagnosis of bacterial vaginosis because of their low sensitivity.

What is the most common gynecologic condition?

Vaginitis (infection of the vagina) is the most common gynecologic condition encountered by physicians in the office. Patients with vaginitis almost always present with a chief complaint of abnormal vaginal discharge. The most common causes of vaginitis are trichomoniasis ( Trichomonas vaginalis infection ), vaginal candidiasis ( Candida vaginalis ), and bacterial vaginosis (BV).

How to detect trichomonas vaginalis?

Trichomonas can also be detected by by DNA probes amplified by polymerase chain reaction. Sample is treated with enzymes that amplify specific regions of trichomonas vaginalis' DNA.

Can trichomonas be coexisting with BV?

Mixed infections are also common, with trichomonas, candida or both coexisting with BV. Physicians have become interested in alternative, office based methods of diagnosing vaginitis. Office microscopy to detect either clue cells, trichomonas or candida may be perceived as cumbersome and inaccurate.

Does bacterial vaginosis cause soreness?

Symptoms are not present in approximately 50 % of women with bacterial vaginosis infection. Bacterial vaginosis is not associated with soreness, itching or irritation. There may be an offensive and classically "fishy" smelling vaginal discharge.

How to diagnose BV?

BV can be diagnosed by using clinical criteria (i.e., Amsel’s diagnostic criteria) ( 999) or by determining the Nugent score from a vaginal Gram stain ( 1000 ). Vaginal Gram stain, considered the reference standard laboratory method for diagnosing BV, is used to determine the relative concentration of lactobacilli (i.e., long gram-positive rods), small gram-negative and gram-variable rods (i.e., G. vaginalis or Bacteroides ), and curved gram-negative rods (i.e., Mobiluncus) characteristic of BV. A Nugent score of 0–3 is consistent with a Lactobacillus -predominant vaginal microbiota, 4–6 with intermediate microbiota (emergence of G. vaginalis ), and 7–10 with BV. Clinical diagnosis of BV by Amsel criteria requires at least three of the following four symptoms or signs:

What is the best test for BV?

In addition to the Amsel criteria, multiple POC tests are available for BV diagnosis. The Osom BV Blue test (Sekisui Diagnostics) detects vaginal sialidase activity ( 1003, 1004 ). The Affirm VP III (Becton Dickinson) is an oligonucleotide probe test that detects high concentrations of G. vaginalis nucleic acids (>5 x 10 5 CFU of G. vaginalis/ mL of vaginal fluid) for diagnosing BV, Candida species, and T. vaginalis. This test has been reported to be most useful for symptomatic women in conjunction with vaginal pH measurement and presence of amine odor (sensitivity of 97%); specificity is 81% compared with Nugent. Finally, the FemExam Test Card (Cooper Surgical) measures vaginal pH, presence of trimethylamine (a metabolic by-product of G. vaginalis ), and proline aminopeptidase ( 1005 ). Sensitivity is 91% and specificity is 61%, compared with Nugent. This test has primarily been studied in resource-poor settings ( 1005 ), and although it has been reported to be beneficial compared with syndromic management, it is not a preferred diagnostic method for BV diagnosis.

What is the Max Vaginal Panel?

The Max Vaginal Panel provides results by an algorithmic analysis of molecular DNA detection of Lactobacillus species ( L. crispatus and L. jensenii) in addition to G. vaginalis, A. vaginae, BVAB2, and Megasphaera type 1. This test has 90.5% sensitivity and 85.8% specificity for BV diagnosis, compared with Amsel criteria and Nugent score. It also provides results for Candida species and T. vaginalis. The Aptima BV detects G. vaginalis, A. vaginae, and certain Lactobacillus species including L. crispatus, L. jensenii, and L. gasseri, with sensitivity and specificity ranging from 95.0% to 97.3% and 85.8% to 89.6%, respectively (using either clinician- or patient-collected vaginal swabs). The three laboratory-developed tests (NuSwab VG, OneSwab BV Panel PCR with Lactobacillus Profiling by qPCR, and SureSwab BV) have to be internally validated before use for patient care yet have good sensitivity and specificity, similar to FDA-cleared assays. BV NAATs should be used among symptomatic women only (e.g., women with vaginal discharge, odor, or itch) because their accuracy is not well defined for asymptomatic women. Despite the availability of BV NAATs, traditional methods of BV diagnosis, including the Amsel criteria, Nugent score, and the Affirm VP III assay, remain useful for diagnosing symptomatic BV because of their lower cost and ability to provide a rapid diagnosis. Culture of G. vaginalis is not recommended as a diagnostic tool because it is not specific. Cervical Pap tests have no clinical utility for diagnosing BV because of their low sensitivity and specificity.

Is BV treatment recommended for women?

Treatment for BV is recommended for women with symptoms. Established benefits of therapy among nonpregnant women are to relieve vaginal symptoms and signs of infection. Other potential benefits of treatment include reduction in the risk for acquiring C. trachomatis, N. gonorrhoeae, T. vaginalis, M. genitalium, HIV, HPV, and HSV-2 ( 971, 986 – 988, 990, 1010 ). No data are available that directly compare the efficacy of oral and topical medications for treating BV.

Can you douch for BV?

Douching might increase the risk for relapse , and no data support use of douching for treatment or symptom relief.

Should women with BV be tested for HIV?

All women with BV should be tested for HIV and other STIs.

Can BV be used during pregnancy?

BV treatment is recommended for all symptomatic pregnant women because symptomatic BV has been associated with adverse pregnancy outcomes , including premature rupture of membranes, preterm birth, intra-amniotic infection, and postpartum endometritis ( 989, 991, 1036 ). Studies have been undertaken to determine the efficacy of BV treatment among this population, including two trials demonstrating that oral metronidazole was efficacious during pregnancy by using the 250 mg 3 times/day regimen ( 1037, 1038 ); however, oral metronidazole administered as a 500 mg 2 times/day regimen can also be used. One trial involving a limited number of participants revealed treatment with oral metronidazole 500 mg 2 times/day for 7 days to be equally effective as metronidazole gel 0.75% for 5 days, with cure rates of 70% by using Amsel criteria to define cure ( 1039 ). Another trial demonstrated a cure rate of 85% by using Gram-stain criteria after treatment with oral clindamycin 300 mg 2 times/day for 7 days ( 1040 – 1043 ).

image